ProShare Advisors LLC Buys 102,732 Shares of The Clorox Company $CLX

ProShare Advisors LLC grew its position in The Clorox Company (NYSE:CLX) by 6.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,737,891 shares of the company’s stock after purchasing an additional 102,732 shares during the period. ProShare Advisors LLC owned approximately 1.44% of Clorox worth $140,787,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Clorox in the 2nd quarter valued at $958,640,000. Bank of America Corp DE purchased a new position in shares of Clorox during the 2nd quarter valued at approximately $179,780,000. Royal Bank of Canada increased its position in Clorox by 20.1% in the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock worth $146,969,000 after buying an additional 237,301 shares during the period. Bank of New York Mellon Corp boosted its stake in Clorox by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock valued at $132,670,000 after buying an additional 29,181 shares in the last quarter. Finally, Confluence Investment Management LLC boosted its position in shares of Clorox by 33.8% in the second quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company’s stock worth $119,075,000 after buying an additional 315,069 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.7%

CLX opened at $88.01 on Friday. The Clorox Company has a twelve month low of $79.12 and a twelve month high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The company has a market cap of $10.64 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 2.94 and a beta of 0.59. The company has a 50-day moving average price of $88.61 and a 200 day moving average price of $100.01.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. During the same quarter in the prior year, the company earned $2.87 earnings per share. The business’s quarterly revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Sell-side analysts expect that The Clorox Company will post 5.66 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a $1.25 dividend. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 5.7%. Clorox’s payout ratio is presently 103.73%.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
• Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
• Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
• Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $95.00 price target on shares of Clorox in a report on Monday, October 19th. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, October 3rd. Morgan Stanley decreased their target price on shares of Clorox from $97.00 to $87.00 and set an “equal weight” rating for the company in a research report on Thursday, October 15th. Wells Fargo & Company decreased their price target on Clorox from $90.00 to $85.00 and set an “equal weight” rating on the stock in a research report on Monday, October 5th. Finally, Barclays lowered their price target on Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a research report on Friday, October 16th. Eleven equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $93.57.

Clorox Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.